PUBLISHER: The Business Research Company | PRODUCT CODE: 1713585
PUBLISHER: The Business Research Company | PRODUCT CODE: 1713585
Genomic Biomarker Global Market Report 2025
A genomic biomarker is a specific genetic sequence or molecular trait within an individual's genome that helps assess disease risk, predict disease progression, or gauge response to a particular treatment. These biomarkers play a crucial role in personalized medicine, enabling the customization of treatments based on an individual's genetic profile.
The primary types of genomic biomarkers are predictive biomarkers and prognostic biomarkers. Predictive biomarkers are used to determine the likelihood of a patient responding to a specific treatment or drug. They are applicable to a range of diseases, including oncology, cardiovascular conditions, neurological disorders, renal issues, and more. Predictive biomarkers provide analytical validation, clinical validation, and clinical utility. They are utilized by various end users, including hospitals, diagnostic centers, research laboratories, and other institutions.
The genomic biomarker market research report is one of a series of new reports from The Business Research Company that provides genomic biomarker market statistics, including genomic biomarker industry global market size, regional shares, competitors with a genomic biomarker market share, detailed genomic biomarker market segments, market trends and opportunities, and any further data you may need to thrive in the genomic biomarker industry. This genomic biomarker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The genomic biomarker market size has grown rapidly in recent years. It will grow from $8.4 billion in 2024 to $9.9 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to growth in awareness of genetic disorders, rise in demand for targeted therapies, increasing utilization of big data in genomics, growth in global genomic databases, and rise in number of biomarker-based clinical trials.
The genomic biomarker market size is expected to see rapid growth in the next few years. It will grow to $18.93 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to growing focus on the availability of personalized medications, rising occurrences of cardiovascular diseases, rising number of patients with neurological diseases, growing investments in genomic research, and growing adoption of personalized nutrition. Major trends in the forecast period include technological advancements, digital health, artificial intelligence, machine learning, and personalized medicine.
The rising prevalence of chronic diseases is anticipated to drive the growth of the genomic biomarker market. Chronic diseases are long-term health conditions that develop gradually and persist over time. This increase in chronic diseases is attributed to aging populations and the growing incidence of lifestyle-related conditions such as obesity and diabetes. Genomic biomarkers facilitate early detection and personalized prevention strategies by identifying genetic predispositions and customizing interventions. This proactive approach aims to reduce prevalence by targeting at-risk individuals before the onset of disease. For example, in September 2023, the World Health Organization (WHO) reported that chronic diseases account for 74% of all global fatalities, with 41 million deaths annually. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the rising prevalence of chronic diseases is driving the growth of genomic biomarkers.
Leading companies in the genomic biomarker market are concentrating on developing advanced products, such as sophisticated liquid biopsy assays, to facilitate comprehensive genomic profiling of solid tumors. A liquid biopsy assay is a diagnostic test that examines genetic material, usually circulating tumor DNA (ctDNA), from a blood sample to detect and monitor cancer. Identifying genomic biomarkers provides insights into specific mutations, gene expression profiles, or other genetic changes associated with cancer. For example, in November 2023, Illumina Inc., a US-based biotechnology company, introduced an advanced liquid biopsy assay, the TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2), for thorough genomic profiling of solid tumors. This assay offers improved analytical sensitivity by detecting low-frequency variants with only 20 ng of cell-free DNA, reduced from 30 ng. It provides results in under four days, significantly accelerating genomic profiling compared to traditional methods. The streamlined workflow and upcoming automation will ease lab integration and enhance efficiency.
In November 2022, Biocare Medical LLC, a US-based provider of immunohistochemistry and FISH instrumentation and reagents, acquired Empire Genomics for an undisclosed amount. This acquisition is intended to substantially boost Biocare Medical LLC's molecular diagnostics capabilities and broaden its range of cancer research tools. Empire Genomics, a US-based company specializing in cancer molecular diagnostics, offers genomic biomarkers.
Major companies operating in the genomic biomarker market are Pfizer Inc., Roche Diagnostics, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Foundation Medicine Inc., QIAGEN N.V., Almac Group Ltd., Myriad Genetics Inc., Invitae Inc., Guardant Health Inc., Novogene Inc., Twist Bioscience Corp., NanoString Technologies Inc., Quanterix Corp., Personalis Inc., GENEWIZ Inc., Agena Bioscience Inc., Creative Diagnostics Ltd., OncoDNA SA, Genome Life Sciences Ltd., Epigenomics AG.
North America was the largest region in the genomic biomarker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic biomarker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the genomic biomarker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The genomic biomarker market consists of sales of genetic testing kits, genotyping arrays, pharmacogenomic panels and cancer genomics panels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Genomic Biomarker Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on genomic biomarker market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for genomic biomarker ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomic biomarker market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Predictive Biomarkers; Prognostic Biomarkers
- 2) By Disease Indication: Oncology; Cardiovascular Diseases; Neurological Diseases; Renal Disorders; Other Disease Indications
- 3) By Validation: Analytical Validation; Clinical Validation; Clinical Utility
- 4) By End-User: Hospitals; Diagnostic Centers; Research Laboratories; Other End Users
- Subsegments:
- 1) By Predictive Biomarkers: Genetic Biomarkers For Disease Susceptibility; Pharmacogenomic Biomarkers For Drug Response; Early Detection Biomarkers For Disease Prediction; Biomarkers For Treatment Response Prediction
- 2) By Prognostic Biomarkers: Biomarkers For Disease Progression; Biomarkers For Outcome Prediction; Survival And Recurrence Biomarkers; Biomarkers For Treatment Efficacy And Prognosis
- Companies Mentioned: Pfizer Inc.; Roche Diagnostics; Thermo Fisher Scientific Inc.; Merck KGaA; Eurofins Scientific SE
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Genomic Biomarker Market Characteristics
3. Genomic Biomarker Market Trends And Strategies
4. Genomic Biomarker Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Genomic Biomarker Growth Analysis And Strategic Analysis Framework
- 5.1. Global Genomic Biomarker PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Genomic Biomarker Market Growth Rate Analysis
- 5.4. Global Genomic Biomarker Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Genomic Biomarker Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Genomic Biomarker Total Addressable Market (TAM)
6. Genomic Biomarker Market Segmentation
- 6.1. Global Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Predictive Biomarkers
- Prognostic Biomarkers
- 6.2. Global Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- 6.3. Global Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Analytical Validation
- Clinical Validation
- Clinical Utility
- 6.4. Global Genomic Biomarker Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Diagnostic Centers
- Other End-User
- 6.5. Global Genomic Biomarker Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Genetic Biomarkers For Disease Susceptibility
- Pharmacogenomic Biomarkers For Drug Response
- Early Detection Biomarkers For Disease Prediction
- Biomarkers For Treatment Response Prediction
- 6.6. Global Genomic Biomarker Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biomarkers For Disease Progression
- Biomarkers For Outcome Prediction
- Survival And Recurrence Biomarkers
- Biomarkers For Treatment Efficacy And Prognosis
7. Genomic Biomarker Market Regional And Country Analysis
- 7.1. Global Genomic Biomarker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Genomic Biomarker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Genomic Biomarker Market
- 8.1. Asia-Pacific Genomic Biomarker Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Genomic Biomarker Market
- 9.1. China Genomic Biomarker Market Overview
- 9.2. China Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Genomic Biomarker Market
- 10.1. India Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Genomic Biomarker Market
- 11.1. Japan Genomic Biomarker Market Overview
- 11.2. Japan Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Genomic Biomarker Market
- 12.1. Australia Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Genomic Biomarker Market
- 13.1. Indonesia Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Genomic Biomarker Market
- 14.1. South Korea Genomic Biomarker Market Overview
- 14.2. South Korea Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Genomic Biomarker Market
- 15.1. Western Europe Genomic Biomarker Market Overview
- 15.2. Western Europe Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Genomic Biomarker Market
- 16.1. UK Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Genomic Biomarker Market
- 17.1. Germany Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Genomic Biomarker Market
- 18.1. France Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Genomic Biomarker Market
- 19.1. Italy Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Genomic Biomarker Market
- 20.1. Spain Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Genomic Biomarker Market
- 21.1. Eastern Europe Genomic Biomarker Market Overview
- 21.2. Eastern Europe Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Genomic Biomarker Market
- 22.1. Russia Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Genomic Biomarker Market
- 23.1. North America Genomic Biomarker Market Overview
- 23.2. North America Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Genomic Biomarker Market
- 24.1. USA Genomic Biomarker Market Overview
- 24.2. USA Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Genomic Biomarker Market
- 25.1. Canada Genomic Biomarker Market Overview
- 25.2. Canada Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Genomic Biomarker Market
- 26.1. South America Genomic Biomarker Market Overview
- 26.2. South America Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Genomic Biomarker Market
- 27.1. Brazil Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Genomic Biomarker Market
- 28.1. Middle East Genomic Biomarker Market Overview
- 28.2. Middle East Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Genomic Biomarker Market
- 29.1. Africa Genomic Biomarker Market Overview
- 29.2. Africa Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Genomic Biomarker Market Competitive Landscape And Company Profiles
- 30.1. Genomic Biomarker Market Competitive Landscape
- 30.2. Genomic Biomarker Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
31. Genomic Biomarker Market Other Major And Innovative Companies
- 31.1. Agilent Technologies Inc.
- 31.2. Illumina Inc.
- 31.3. PerkinElmer Inc.
- 31.4. Beckman Coulter Inc.
- 31.5. Bio-Rad Laboratories Inc.
- 31.6. Foundation Medicine Inc.
- 31.7. QIAGEN N.V.
- 31.8. Almac Group Ltd.
- 31.9. Myriad Genetics Inc.
- 31.10. Invitae Inc.
- 31.11. Guardant Health Inc.
- 31.12. Novogene Inc.
- 31.13. Twist Bioscience Corp.
- 31.14. NanoString Technologies Inc.
- 31.15. Quanterix Corp.
32. Global Genomic Biomarker Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Genomic Biomarker Market
34. Recent Developments In The Genomic Biomarker Market
35. Genomic Biomarker Market High Potential Countries, Segments and Strategies
- 35.1 Genomic Biomarker Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Genomic Biomarker Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Genomic Biomarker Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
- 250423_r33487_Genomic_Biomarker_GMR_2025
